This new combo product will be used to manage heavy menstrual bleeding associated with uterine fibroids, and moderate to severe pain associated with endometriosis.
Clarivate’s recently released Drugs to Watch 2024 report highlights 13 important drugs and a handful of new technologies that could be transformative this year.
One in five U.S. Medicaid-insured children are exposed to major drug interactions annually, with higher risk in those with multiple medical or mental health conditions.